BEVERLY HILLS, Calif., March 06, 2017 -- Barfresh Food Group, Inc. (OTCQB:BRFH), a developer, manufacturer, and distributor of frozen, ready-to-blend beverages, announced today that Riccardo Delle Coste, the Company's Chief Executive Officer, and Joe Tesoriero, the Company's Chief Financial Officer, will be presenting at the 29th Annual ROTH Conference, to be held March 12-15, 2017, at The Ritz-Carlton Laguna Niguel in California.
The Barfresh investor presentation is scheduled for Monday, March 13, 2017, at 5:30 pm PT. The presentation will be webcast live and archived at www.barfresh.com. Visitors to the website should select the "Investor” tab and navigate to the “Presentations” section to access the webcast.
About Barfresh Food Group
Barfresh Food Group, Inc. (OTCQB:BRFH) is a developer, manufacturer and distributor of ready-to-blend beverages, including smoothies, shakes and frappes, primarily for restaurant chains and the foodservice industry. The company's proprietary, patented system uses portion-controlled pre-packaged beverage ingredients that deliver freshly made frozen beverages that are quick, cost efficient, better for you and without waste. PepsiCo North America Beverages, a division of PepsiCo, Inc., is the exclusive sales representative in North America within the food service channel for Barfresh's full line of beverages. Barfresh has an exclusive distribution partnership with the leading food distributor in North America. For more information, please visit www.barfresh.com.
Contact John Mills ICR 646-277-1254 [email protected] Jeff Sonnek ICR 646-277-1263 [email protected]


Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates 



